Gem Aromatics Limited reported mixed financial results for the quarter ended June 30, 2026 (Q1FY27), with top-line growth contrasted by a sharp contraction in operating profitability and a consolidated net loss. Standalone revenue stood at ₹830 crore, rising 8.6% from ₹764 crore in the corresponding quarter of the previous fiscal year. However, standalone earnings before interest, taxes, depreciation and amortisation (EBITDA) fell 42.8% to ₹85 crore, down from ₹148.5 crore in Q1FY26.

The decline in operating profit led to significant margin compression. The standalone EBITDA margin for the quarter was 10.18%, compared to 16.95% in the prior year period. Despite the pressure on operating metrics, standalone net profit increased 12.3% to ₹73 crore, up from ₹65 crore in Q1FY26. On a consolidated basis, however, the company reported a net loss of ₹7.9 crore, compared to a profit in the prior year period. This divergence was driven by higher depreciation of ₹9.1 crore following the capitalization of a substantial portion of the new Dahej facility under Krystal Ingredients Private Limited.

What the Numbers Show

The divergence between revenue growth and operating profit contraction highlights margin pressure during the quarter. While topline expanded by nearly 9%, standalone EBITDA declined by over 40%, indicating that cost structures or input prices may have risen faster than sales realizations. The management attributed this to product mix shifts, higher raw material costs in the clove business due to supply disruptions in Madagascar, and the higher operating cost base of the new plant. The consolidated bottom line was further impacted by the timing mismatch where costs for the new facility kicked in before revenue from higher-margin specialty products scaled up.

Operational Updates and New Verticals

Management highlighted progress at the Dahej facility, which is moving into the next phase of operations with a focus on strengthening core customer engagement. Key updates include:

• Safranal: Commercial production has commenced. Revenue contribution is expected towards the end of Q2FY27, with meaningful contribution from Q3FY27 as commercial supplies scale up.
• Cooling Agents: Production of Gemcool 3, Gemcool 5, and Gemcool 23 has commenced. Customer audits are complete, and initial orders have been secured. Meaningful contribution is expected from Q3FY27.
• Phenol Derivatives: Trial production is expected towards the end of Q2FY27. Commercial production is targeted during Q3FY27, with meaningful revenue contribution expected from Q4FY27.

The company aims to reduce dependence on the traditional mint portfolio and build a balanced mix across non-mint and higher-value specialty products. By FY28, Krystal products are expected to contribute more than 50% of overall revenue.

Challenges and Outlook

The clove business was impacted by floods in Madagascar, affecting raw material availability and pricing. Port closures in Toamasina delayed shipments by approximately 30 days, though supply has since normalized. Management noted that demand remains strong, particularly from the Western Hemisphere, with exports ramping up as shipping challenges ease.

Looking ahead, the company expects a gradual improvement phase as newer product verticals scale up. Operating leverage is expected to support margins and profitability over the medium term as capacity utilization improves. The company has also approved the incorporation of a Brazil subsidiary to expand distribution reach in Latin America.

Earnings Call Details

Gem Aromatics hosted an investors and analysts conference call on August 14, 2026, to discuss these unaudited financial results. Senior leadership including Yash Parekh (MD & CEO) and Aadit Shah (CEO's Office) participated in the session. The transcript of the call has been filed with stock exchanges pursuant to Regulation 30 of SEBI LODR Regulations, 2015.

Gem Aromatics Limited shareholders approved the company’s audited financial statements for the fiscal year ended March 31, 2026, during its 29th Annual General Meeting held on August 19, 2026. The meeting, conducted via video conferencing in compliance with SEBI Listing Regulations and the Companies Act 2013, focused on board restructuring, director remuneration approvals, and the adoption of standalone and consolidated financial statements.

The statutory auditors, M/s. Chhajed & Doshi, Chartered Accountants, issued an unqualified report for FY26, with no adverse remarks or qualifications noted in either the Auditor’s Report or the Secretarial Auditor’s Report from M/s. N. L. Bhatia & Associates.

Voting Results Overview

The scrutinizer’s report reveals strong shareholder backing for all 13 resolutions. Out of a total shareholding of 5,22,37,138 shares, approximately 4,13,07,542 votes were polled, representing a 79.08% participation rate. Promoter and promoter group shareholders, holding 3,00,08,139 shares, voted unanimously (100%) in favour of every resolution through remote e-voting.

Public institutional shareholders, holding 30,65,424 shares, also cast all their polled votes (15,29,258) in favour. Dissent was minimal among public non-institutional shareholders, who hold 1,91,63,575 shares. Across most resolutions, more than 99.8% of polled votes from this segment were in favour.

Board Appointments and Reappointments

Shareholders passed ordinary resolutions to reappoint Mrs. Kaksha Vipul Parekh, who retires by rotation, as a director. Similarly, Mr. Yash Parekh, Managing Director and Chief Executive Officer, was reappointed after retiring by rotation.

The meeting also approved several special resolutions regarding board composition:

• Appointment of Mr. Dinesh Vasu Thekkepanakkal as a Whole-Time Director effective May 21, 2026.
• Appointment of Mr. Nandan Narula as a Non-Executive Independent Director for a five-year term starting May 21, 2026.
• Approval of consultancy fees for Mr. Shrenik Kishorbhai Vora, Non-Executive Non-Independent Director.

Remuneration packages for the balance of their current terms were approved for Mrs. Kaksha Vipul Parekh (Whole-Time Director and CFO), Mr. Yash Parekh (MD & CEO), and Mr. Vipul Parekh (Whole-Time Director).

Governance and Auditors

The company ratified the remuneration for M/s. Y. R. Doshi & Associates Cost Accountants as Cost Auditors for FY27. Additionally, M/s. N. L. Bhatia & Associates were appointed as Secretarial Auditors.

During the proceedings, Mrs. Kaksha Vipul Parekh recused herself from voting on agenda items related to her own appointment and remuneration, as well as those concerning other interested directors. Mr. Nandan Narula, Independent Director and Chairman of the Audit Committee, assumed the chair for these specific items to ensure compliance with conflict-of-interest protocols.

What the Numbers Show

The presence of 62 members at the AGM, comprising seven promoters and 55 public shareholders, indicates broad participation in the governance process. The clean audit report for FY26 suggests no material irregularities in financial reporting or corporate functioning during the period under review. The near-unanimous support from both promoter and public shareholders underscores confidence in the board’s proposed strategic and governance changes.

The meeting concluded at 1:07 pm IST after a question-and-answer session where management addressed member queries regarding company operations and strategy.